V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250006884 | 250004859 | null | null | Curative (C) | 2013-08-30 | 2013-09-01 | RUXOLITINIB | 02 | null | 250030530 | RUXOLITINIB |
| 250006885 | 250009625 | 1.7 | 67.6 | Palliative (P) | 2015-08-21 | 2015-08-21 | RUXOLITINIB | null | N | 250030531 | RUXOLITINIB |
| 250006887 | 250004861 | 1.86 | 73 | null | 2017-05-22 | 2017-05-22 | PEG INTERFERON | N | N | 250030533 | RUXOLITINIB |
| 250006888 | 250004862 | 1.56 | 73.7 | Palliative (P) | 2016-09-08 | 2016-09-09 | Rituximab | N | N | 250030535 | AML18 TRIAL |
| 250006889 | 250004862 | 1.61 | 88.9 | Curative (C) | 2017-02-03 | 2017-02-03 | RUXOLITINIB | N | N | 250030535 | RUXOLITINIB |
| 250006890 | 250011574 | 1.7 | 71.2 | Neo-adjuvant (N) | 2018-01-23 | 2018-01-23 | Bendamustine+Rituximab (1st Course) | 2 | N | 250030538 | PEG INTERFERON |
| 250006891 | 250004863 | 1.66 | 70.8 | Palliative (P) | 2016-05-27 | 2016-09-02 | RUXOLITINIB | 02 | N | 250030542 | CHLORAMBUCIL + RITUXIMAB |
| 250006892 | 250004864 | 1.77 | 0 | Not known (9) | 2015-10-06 | 2015-10-14 | RUXOLITINIB | N | N | 250030543 | RUXOLITINIB |
| 250006893 | 250004865 | 1.76 | 69 | null | 2013-01-30 | 2013-02-06 | Rituximab | null | N | 250030546 | PEG INTERFERON |
| 250006894 | 250004865 | 1.67 | 80.4 | Disease modification (D) | 2016-08-27 | 2016-09-10 | RUXOLITINIB | 2 | N | 250030546 | RUXOLITINIB |
| 250006895 | 250004865 | null | 65 | Disease modification (D) | 2015-03-30 | 2015-03-30 | CARBO + GEFITINIB + PEMETREXED | 01 | null | 250030546 | RUXOLITINIB |
| 250006896 | 250004865 | 0 | 65.5 | Palliative (P) | 2013-04-14 | 2013-09-19 | NHL 2003 Gp B COP | N | N | 250030546 | ATG + BUSULFAN + FLUDARABINE |
| 250006897 | 250012366 | 1.8 | 79.6 | Curative (C) | 2018-05-30 | 2018-06-12 | RUXOLITINIB | N | N | 250030559 | RUXOLITINIB |
| 250006898 | 250004866 | 1.6 | 78.5 | Not known (9) | 2015-03-14 | 2015-03-21 | Rituximab | 02 | null | 250030572 | RUXOLITINIB |
| 250006899 | 250004867 | 0 | 0 | Palliative (P) | 2013-10-09 | 2013-10-22 | BUSULFAN | N | N | 250030573 | PEG INTERFERON |
| 250006900 | 250004868 | 0 | 74.2 | Disease modification (D) | 2016-12-08 | 2017-04-03 | Imatinib 400mg | N | N | 250030576 | RUXOLITINIB |
| 250006901 | 250004869 | null | null | Palliative (P) | 2015-06-03 | 2015-06-03 | Rituximab | 01 | N | 250030577 | RUXOLITINIB |
| 250006902 | 250009628 | 1.65 | null | Palliative (P) | 2014-09-18 | 2014-09-18 | RUXOLITINIB | 02 | N | 250030583 | RUXOLITINIB |
| 250006903 | 250009628 | 1.65 | 96.1 | Palliative (P) | 2015-07-22 | 2015-08-05 | CHOP R - 21 days | 02 | N | 250030583 | IMATINIB |
| 250006904 | 250009628 | 1.71 | 111.1 | p | null | 2014-03-26 | RUXOLITINIB | N | N | 250030583 | INTERFERON |
| 250006905 | 250009628 | null | 108 | Palliative (P) | 2015-12-29 | 2015-12-29 | RUXOLITINIB | 2 | N | 250030583 | RUXOLITINIB |
| 250006906 | 250009628 | 1.73 | 105.6 | Disease modification (D) | 2015-02-11 | 2015-12-13 | ANAGRELIDE | 1 | null | 250030583 | IMATINIB |
| 250006907 | 250009628 | 0 | 86.5 | Palliative (P) | 2016-03-23 | 2016-03-23 | Rituximab | 2 | N | 250030583 | BORTEZOMIB + THALIDOMIDE |
| 250006908 | 250004870 | 1.58 | 0 | Disease modification (D) | 2017-02-05 | 2017-01-27 | CHOP R - 21 days | 02 | N | 250030610 | RUXOLITINIB |
| 250006909 | 250004871 | 1.63 | 49 | Disease modification (D) | 2018-03-22 | 2018-03-23 | IMATINIB | 02 | N | 250030611 | RUXOLITINIB |
| 250006910 | 250004871 | 1.65 | 67.5 | Palliative (P) | 2014-12-24 | 2015-01-06 | RUXOLITINIB | 2 | null | 250030611 | BORTEZOMIB |
| 250006911 | 250004872 | 1.61 | null | Palliative (P) | 2016-12-21 | 2016-12-22 | Imatinib 400mg | 02 | N | 250030620 | IMATINIB |
| 250006913 | 250004874 | 1.75 | 92 | Disease modification (D) | 2015-08-19 | 2015-08-30 | DA 3 + 10 | N | N | 250030627 | NOT MATCHED |
| 250006914 | 250004875 | 1.67 | null | Disease modification (D) | 2015-12-28 | 2015-12-28 | Busulfan Oral | N | N | 250030628 | RUXOLITINIB |
| 250006915 | 250004876 | 1.78 | 80 | Palliative (P) | 2013-08-05 | 2013-08-05 | Azacitidine | N | N | 250030630 | RUXOLITINIB |
| 250006916 | 250004876 | 1.51 | 66 | Disease modification (D) | 2017-05-26 | 2017-05-27 | RUXOLITINIB | N | N | 250030630 | RUXOLITINIB |
| 250006917 | 250011577 | null | 55.3 | Disease modification (D) | 2016-01-02 | 2016-01-05 | RUXOLITINIB | 01 | N | 250030640 | DA |
| 250006918 | 250004877 | 1.85 | 100.6 | Curative (C) | 2013-02-27 | 2013-03-26 | PEG INTERFERON | N | N | 250030647 | RUXOLITINIB |
| 250006919 | 250004877 | 0 | 15 | Disease modification (D) | 2017-07-27 | 2017-07-28 | RUXOLITINIB | 2 | N | 250030647 | RITUXIMAB |
| 250006920 | 250004878 | null | 89 | Palliative (P) | 2018-03-14 | 2018-03-21 | RUXOLITINIB | Y | N | 250030653 | RUXOLITINIB |
| 250006921 | 250004878 | 1.74 | 81.4 | Disease modification (D) | 2016-01-29 | 2016-02-04 | RUXOLITINIB | 2 | N | 250030653 | RUXOLITINIB |
| 250006922 | 250004878 | 1.62 | null | Neo-adjuvant (N) | 2016-02-12 | 2016-03-02 | Rituximab (Maintenance) | N | N | 250030653 | ANAGRELIDE |
| 250006923 | 250004879 | null | 72 | Curative (C) | 2014-12-10 | 2015-02-09 | Rituximab | 02 | N | 250030659 | RUXOLITINIB |
| 250006924 | 250004880 | 1.59 | 61.3 | Palliative (P) | 2013-10-05 | 2013-11-04 | BENDAMUSTINE + RITUXIMAB | N | N | 250030665 | IMATINIB |
| 250006926 | 250004882 | 0 | 63.5 | Palliative (P) | 2016-07-01 | 2016-07-09 | RUXOLITINIB | N | N | 250030673 | BUSULPHAN |
| 250006927 | 250004883 | null | 58.2 | Disease modification (D) | 2014-06-20 | 2014-06-20 | RUXOLITINIB | N | N | 250030675 | TRIAL |
| 250006928 | 250004884 | 1.66 | null | Disease modification (D) | 2017-12-19 | 2017-12-19 | RUXOLITINIB | 2 | N | 250030676 | AZACITIDINE |
| 250006929 | 250009633 | 0 | 0 | Disease modification (D) | 2015-01-17 | 2015-01-19 | Rituximab | N | N | 250030677 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 250006930 | 250004885 | 1.85 | 82.1 | Curative (C) | 2013-09-04 | 2013-09-04 | RUXOLITINIB | 02 | N | 250030681 | RUXOLITINIB |
| 250006931 | 250004885 | 0 | 0 | Palliative (P) | 2015-09-19 | 2015-09-19 | ANAGRELIDE | null | N | 250030681 | RUXOLITINIB |
| 250006932 | 250004886 | 1.73 | null | p | 2014-08-09 | 2014-08-16 | RUXOLITINIB | 2 | N | 250030684 | PEG INTERFERON |
| 250006933 | 250004887 | null | 0 | Curative (C) | 2017-09-20 | 2017-09-20 | Nilotinib | 01 | N | 250030685 | TRIAL |
| 250006934 | 250004888 | null | 121.4 | Curative (C) | 2015-02-25 | 2015-02-25 | Rituximab | 02 | N | 250030686 | RUXOLITINIB |
| 250006935 | 250004889 | 1.62 | 0 | Palliative (P) | 2016-07-28 | 2016-07-28 | RUXOLITINIB | N | N | 250030687 | RUXOLITINIB |
| 250006936 | 250004890 | 1.73 | 73.8 | Disease modification (D) | 2016-04-21 | 2016-04-21 | RUXOLITINIB | N | N | 250030689 | PEG INTERFERON |